Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine QD vs BID in Alzheimer's Dementia
NCT02553928Phase 4Completed
- Sponsor
- Lundbeck
- Start
- Oct 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of memantine in Alzheimer's disease (AD), sponsored by Lundbeck. Started Oct 2015; status: completed.
02
Drugs
memantine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02553928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02553928.